Item 1 of this Form 10-Q for information about our reasonably possible aggregate loss estimate and judicial, regulatory and legal proceedings. 
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 
The table below presents purchases made by or on behalf of Group Inc. or any “affiliated purchaser” (as defined in Rule 10b-18(a)(3) under the Exchange Act) of our common stock during the three months ended September 2025. 
Total
Shares
Purchased
Average
Price Paid
Per Share
Total Shares
Purchased as
Part of a Publicly
Announced Program
Dollar Value of Remaining Authorized Repurchases 
($ in millions)
July
1,884,056
$
719.24

1,883,981
$
35,645

August
899,162
$
717.25

899,162
$
35,000

September
–
$
–

–
$
35,000

Total
2,783,218
2,783,143
In the table above, total shares purchased included 75 shares during July 2025 remitted to satisfy statutory withholding taxes related to share-based awards.
During the first quarter of 2025, our Board approved a share repurchase program authorizing repurchases of up to $40 billion of our common stock. This program replaced our previous share repurchase program and has no set expiration or termination date. The share repurchases are effected primarily through regular open-market purchases (which may include repurchase plans designed to comply with Rule 10b5-1 and accelerated share repurchases), the amounts and timing of which are determined primarily by our current and projected capital position, and capital deployment opportunit

--- CHUNK ---

Item 1A of the 2024 Form 10-K.
These statements may relate to, among other things, (i) our future plans and results, including our target ROE, ROTE, efficiency ratio, CET1 capital ratio and firmwide total credit alternative assets, and how they can be achieved, (ii) trends in or growth opportunities for our businesses, including the timing, costs, profitability, benefits and other aspects of business and strategic initiatives, such as OneGS 3.0, and their impact on our efficiency ratio, (iii) the opportunities and challenges presented by AI, (iv) our Investment banking fees backlog and future advisory and capital markets results, (v) expenses we may incur, including the level of future compensation expense, (vi) the projected growth of our deposits and other funding, (vii) our business and expense savings initiatives, (viii) our planned benchmark debt issuances, (ix) our credit exposures, (x) our expected provision for credit losses and the adequacy of our allowance for credit losses, (xi) the narrowing of our consumer business, (xii) the objectives and effectiveness of our BCP, information security program, risk management and liquidity policies, (xiii) our resolution plan and its implications for stakeholders, (xiv) the effect of changes to regulations, and our future status, activities or reporting under banking and financial regulation, (xv) our expected tax rate, (xvi) the future state of our liquidity and regulatory capital ratios, and our prospective capital distributi

--- CHUNK ---

1,883,981
$
35,645

August
899,162
$
717.25

899,162
$
35,000

September
–
$
–

–
$
35,000

Total
2,783,218
2,783,143
In the table above, total shares purchased included 75 shares during July 2025 remitted to satisfy statutory withholding taxes related to share-based awards.
During the first quarter of 2025, our Board approved a share repurchase program authorizing repurchases of up to $40 billion of our common stock. This program replaced our previous share repurchase program and has no set expiration or termination date. The share repurchases are effected primarily through regular open-market purchases (which may include repurchase plans designed to comply with Rule 10b5-1 and accelerated share repurchases), the amounts and timing of which are determined primarily by our current and projected capital position, and capital deployment opportunities, but which may also be influenced by the evolution of current and future regulatory capital requirements, general market conditions and the prevailing price and trading volumes of our common stock. 
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the three months ended September 2025, no directors or executive officers 
entered into
, modified or 
terminated
, contracts, instructions or written plans for the sale or purchase of Group Inc.’s securities that were intended to satisfy the affirmative defense conditions of Rule 10b5-1 or that constituted non-Rule 10b5-1 trading arrangements (as defined in Item 408 of Regulati